SCHEMBL21226914

SCHEMBL21226914

COB(OC)c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.52
▸ LMNA P02545 2/20 0.43
▸ KMT2A Q03164 6/20 0.42
▸ MEN1 O00255 5/20 0.42
▸ MAPT P10636 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ ATM Q13315 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ ADORA2A P29274 2/20 0.42
▸ ADORA1 P30542 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ ADORA2B P29275 1/20 0.42
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ NFKB2 Q00653 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23869937 0.81 L3MBTL1 (0.53) L3MBTL1LMNAKMT2AMEN1MAPT
SCHEMBL371042 0.75 L3MBTL1 (0.74) L3MBTL1LMNAKMT2AMEN1MAPT
SCHEMBL25054533 0.74 MEN1 (0.49) L3MBTL1LMNAKMT2AMEN1MAPT
SCHEMBL19023810 0.72 KMT2A (0.61) L3MBTL1LMNAKMT2AMEN1MAPT
SCHEMBL14603340 0.72 L3MBTL1 (0.52) L3MBTL1LMNAKMT2AMEN1MAPT
SCHEMBL17720978 0.72 L3MBTL1 (0.70) L3MBTL1LMNAKMT2AMEN1MAPT
SCHEMBL75848 0.72 L3MBTL1 (0.70) L3MBTL1LMNAKMT2AMEN1MAPT
SCHEMBL6112014 0.72 L3MBTL1 (0.70) L3MBTL1LMNAKMT2AMEN1MAPT
SCHEMBL18212420 0.72 L3MBTL1 (0.70) L3MBTL1LMNAKMT2AMEN1MAPT
SCHEMBL7646098 0.71 S1PR1 (0.66) L3MBTL1LMNAKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200295270-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-09-17 — — US disclosed
US-20190280218-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2019-09-12 — — US disclosed
US-10374170-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2019-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10374170-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 L3MBTL1 1480/4885LMNA 3497/4885KMT2A 1267/4885
US-20190280218-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 L3MBTL1 1480/4885LMNA 3497/4885KMT2A 1267/4885
US-20200295270-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, EFNA1, EPCAM L3MBTL1 2186/4885LMNA 2573/4885KMT2A 3247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback